Challenge Trial of PfSPZ-LARC2 Vaccine in Burkina Faso

NCT07730177 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Malaria (Plasmodium Falciparum)

Interventions

BIOLOGICAL: PfSPZ-LARC2 Vaccine
BIOLOGICAL: PfSPZ Challenge
OTHER: Normal Saline

Sponsor

Sanaria Inc.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]